Senior Director, Financial Planning & Analysis - R&D

Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.

At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at , and follow us on X, Linked In and Facebook.

The Senior Director, FP&A serves as a strategic finance leader responsible for advancing Dyne’s financial planning, forecasting, reporting, and decision-support capabilities across the Research & Development organization. This role partners closely with Finance leadership, the CFO, functional leaders, program and project teams, and cross-functional stakeholders to translate scientific, operational, and corporate priorities into disciplined financial plans, actionable insights, and clear executive-level recommendations.

This leader is a strategic leader who inspires action, manages interdependencies, allocates resources effectively, and influences decisions across functions. The role requires deep FP&A expertise, strong business judgment, and the ability to synthesize complex financial, operational, and portfolio information to guide planning, investment decisions, scenario modeling, resource allocation, and long-range financial strategy. This leader strengthens scalable FP&A processes, tools, reporting, and operating rhythms to support Dyne’s continued growth and mission of delivering meaningful outcomes for patients.

This role is based in Waltham, MA.

• Lead annual budgeting, quarterly forecasting, long-range planning, and scenario modeling processes across R&D functions:
  Research, Clinical Development, Regulatory and Portfolio Strategy & Operations and the cross-functional program leadership team
• Partner with the VP, FP&A to develop, manage, and continuously improve Dyne’s enterprise planning calendar, planning assumptions, financial models, templates, reporting packages, and governance processes
• Serve as a trusted finance business partner to R&D functions:
  Research, Clinical Development, Regulatory and Portfolio Strategy & Operations and the cross-functional program leadership team, providing financial insights that support strategic decision-making, portfolio prioritization, operating discipline, and resource allocation
• Translate program timelines, clinical development plans, headcount plans, vendor commitments, and functional priorities into clear financial forecasts and actionable recommendations
• Partner closely with the program leadership team and Clinical Operations to develop and manage a live clinical trial forecasting model that clearly identifies key assumptions and drivers, enabling robust scenario planning and informed investment decisions
• Lead program- and function-level budget reviews, challenging assumptions, identifying risks and opportunities, and ensuring alignment between financial plans, corporate goals, program milestones, and functional priorities
• Develop and maintain robust financial models, dashboards, and reporting tools that provide visibility into spend, cash runway, operating performance, clinical and program costs, headcount, and key business drivers
• Prepare and present executive-ready financial analyses, variance explanations, forecast updates, and recommendations for Finance leadership, the CFO, senior leadership, and other governance forums as…